Literature DB >> 11748241

The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution.

Thomas Linnemann1, Christina Kiel, Peter Herter, Christian Herrmann.   

Abstract

Small GTPases of the Ras family are major players of signal transduction in eukaryotic cells. They receive signals from a number of receptors and transmit them to a variety of effectors. The distribution of signals to different effector molecules allows for the generation of opposing effects like proliferation and differentiation. To understand the specificity of Ras signaling, we investigated the activation of RalGDS, one of the Ras effector proteins with guanine-nucleotide exchange factor activity for Ral. We determined the GTP level on RalA and showed that the highly conserved Ras binding domain (RBD) of RalGDS, which mediates association with Ras, is important but not sufficient to explain the stimulation of the exchange factor. Although a point mutation in the RBD of RalGDS, which abrogates binding to Ras, renders RalGDS independent to activated Ras, an artificially membrane-targeted version of RalGDS lacking its RBD could still be activated by Ras. The switch II region of Ras is involved in the activation, because the mutant Y64W in this region is impaired in the RalGDS activation. Furthermore, it is shown that Rap1, which was originally identified as a Ras antagonist, can block Ras-mediated RalGDS signaling only when RalGDS contains an intact RBD. In addition, kinetic studies of the complex formation between RalGDS-RBD and Ras suggest that the fast association between RalGDS and Ras, which is analogous to the Ras/Raf case, achieves signaling specificity. Conversely, the Ras x RalGDS complex has a short lifetime of 0.1 s and Rap1 forms a long-lived complex with RalGDS, possibly explaining its antagonistic effect on Ras.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748241     DOI: 10.1074/jbc.M110800200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex.

Authors:  C Kiel; T Selzer; Y Shaul; G Schreiber; C Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

2.  Early thyroid hormone-induced gene expression changes in N2a-β neuroblastoma cells.

Authors:  Gabriela Bedó; Angel Pascual; Ana Aranda
Journal:  J Mol Neurosci       Date:  2010-05-27       Impact factor: 3.444

3.  Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.

Authors:  Matthew J Smith; Mitsuhiko Ikura
Journal:  Nat Chem Biol       Date:  2014-01-19       Impact factor: 15.040

4.  The IQGAP-related protein DGAP1 mediates signaling to the actin cytoskeleton as an effector and a sequestrator of Rac1 GTPases.

Authors:  Vedrana Filić; Maja Marinović; Jan Faix; Igor Weber
Journal:  Cell Mol Life Sci       Date:  2014-03-25       Impact factor: 9.261

5.  The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism.

Authors:  Hao Zhang; Yu-Chung Chang; Mark L Brennan; Jinhua Wu
Journal:  J Mol Cell Biol       Date:  2013-11-28       Impact factor: 6.216

6.  Improved binding of raf to Ras.GDP is correlated with biological activity.

Authors:  Christina Kiel; Daniel Filchtinski; Michael Spoerner; Gideon Schreiber; Hans Robert Kalbitzer; Christian Herrmann
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

7.  Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.

Authors:  Benjamin Stieglitz; Christine Bee; Daniel Schwarz; Ozkan Yildiz; Anna Moshnikova; Andrei Khokhlatchev; Christian Herrmann
Journal:  EMBO J       Date:  2008-07-03       Impact factor: 11.598

8.  The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.

Authors:  K Osei-Sarfo; L Martello; S Ibrahim; A Pellicer
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

9.  Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.

Authors:  Tomoyuki Tanaka; Roger L Williams; Terence H Rabbitts
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

10.  Specific Conformational States of Ras GTPase upon Effector Binding.

Authors:  Julie Baussand; Jens Kleinjung
Journal:  J Chem Theory Comput       Date:  2012-11-06       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.